VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL
Latest Information Update: 29 Aug 2024
At a glance
- Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms VITAL-DEP
- 27 Aug 2024 Planned End Date changed from 1 Feb 2025 to 1 Apr 2025.
- 12 Dec 2021 Primary endpoint has not been met (Mood scores) as per results published in the JAMA: the Journal of the American Medical Association
- 12 Dec 2021 Primary endpoint has not been met (Depression) as per results published in the JAMA: the Journal of the American Medical Association